Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of AC Followed by Paclitaxel, Trastuzumab, and Lapatinib in HER2+ Breast Cancer
NCT00482391Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Mar 2007
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by Memorial Sloan Kettering Cancer Center. Started Mar 2007; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00482391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00482391.